John F. Paolini, Chief Medical Officer: Kiniksa Pharmaceuticals International KNSA Sell · Filed 24/07/25

Trade details

Type: Insider sale
Amount: $228,886.6
Shares · price: 8,446 sh · $27.10 a share
Held after: 47,903 sh
Stock: Kiniksa Pharmaceuticals International KNSA
Person: John F. PaoliniChief Medical Officer
Trade date: 24/07/23
Filed: 24/07/25
Days to filing: 2 days

Sold 15.0% of holdings

Share of holding sold: 15.0%

Kiniksa Pharmaceuticals International trades, last 26 weeks

What else happened in Kiniksa Pharmaceuticals International around then

Filed or reported within 30 days of the trade day · 24/06/23~24/08/22

John F. Paolini's recent trades

John F. PaoliniChief Medical Officer
Sell10b5-1 planKiniksa Pharmaceuticals International
Sell10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$2M
37,327 sh
$2M
Filed 05/05
Traded 05/01
John F. PaoliniChief Medical Officer
Sell10b5-1 planKiniksa Pharmaceuticals International
Sell10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$1.1M
21,097 sh
$1.1M
Filed 05/05
Traded 05/01
John F. PaoliniChief Medical Officer
Planned sale10b5-1 planKiniksa Pharmaceuticals International
Planned sale10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$3.1M
58,424 sh
$3.1M
Filed 05/01
Traded 05/01
John F. PaoliniChief Medical Officer
Sell10b5-1 planKiniksa Pharmaceuticals International
Sell10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$997.4K
22,223 sh
$997.4K
Filed 03/04
Traded 03/02
John F. PaoliniChief Medical Officer
Sell10b5-1 planKiniksa Pharmaceuticals International
Sell10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$533.2K
12,063 sh
$533.2K
Filed 03/04
Traded 03/02

John F. Paolini, Chief Officer — sold $228.9K of Kiniksa Pharmaceuticals International KNSA · 15.0% of holdings · 10b5-1 plan | Whalegun